FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, George O. Waring IV, MD, FACS, reports ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results